Abstract:Nonalcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of liver damage from the more prevalent (75%–80%) and nonprogressive nonalcoholic fatty liver (NAFL) category to its less common and more ominous subset, nonalcoholic steatohepatitis (NASH). NAFLD is now the most common cause of chronic liver disease in the developed world and is a leading indication for liver transplantation in United States (US). The global prevalence of NAFLD is estimated to be 25%, with the lowest prevalence in Africa (13.5%) and highest in the Middle East (31.8%) and South America (30.4%). The increasing incidence of NAFLD has been associated with the global obesity epidemic and manifestation of metabolic complications, including hypertension, diabetes, and dyslipidemia. The rapidly rising healthcare and economic burdens of NAFLD warrant institution of preventative and treatment measures in the high-risk sub-populations in an effort to reduce the morbidity and mortality associated with NAFLD. Genetic, demographic, clinical, and environmental factors may play a role in the pathogenesis of NAFLD. While NAFLD has been linked with various genetic variants, including PNPLA-3, TM6SF2, and FDFT1, environmental factors may predispose individuals to NAFLD as well. NAFLD is more common in older age groups and in men. With regards to ethnicity, in the US, Hispanics have the highest prevalence of NAFLD, followed by Caucasians and then African-Americans. NAFLD is frequently associated with the components of metabolic syndrome, such as type 2 diabetes mellitus (T2DM), obesity, hypertension, and dyslipidemia. Several studies have shown that the adoption of a healthy lifestyle, weight loss, and pro-active management of individual components of metabolic syndrome can help to prevent, retard or reverse NAFLD-related liver damage. Independently, NAFLD increases the risk of premature cardiovascular disease and associated mortality. For this reason, a case can be made for screening of NAFLD to facilitate early diagnosis and to prevent the hepatic and extra-hepatic complications in high risk sub-populations with morbid obesity, diabetes, and other metabolic risk factors.

Extrahepatic complications of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

Research Advances in Extrahepatic Diseases Associated with Nonalcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases

Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD

The Role of Hepatic Fat Accumulation in Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease

NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?

From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences

Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations

Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review

Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis

Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease

Molecular Mechanisms and Mediators of Hepatotoxicity Resulting from an Excess of Lipids and Non-Alcoholic Fatty Liver Disease